Drug intelligence / Profile preview

human cord tissue mesenchymal stromal cells

Development stage
Phase 1
Lead developer
Duke University
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

Human cord tissue mesenchymal stromal cells (hCT-MSC) is an allogeneic cell-based biologic therapy developed by Dr. Joanne Kurtzberg and her research team at the Marcus Center for Cellular Cures at Duke University School of Medicine. The therapy consists of mesenchymal stromal cells derived from healthy donor umbilical cord tissue. It is specifically being investigated for the treatment of COVID-19 related acute respiratory distress syndrome (ARDS). The mechanism of action involves potent anti-inflammatory and immunomodulatory effects intended to counteract the systemic cytokine release syndrome (cytokine storm) and promote lung tissue regeneration. The therapy is administered as three daily intravenous infusions and has been evaluated in the Phase 1/2a MASC clinical trial.

Other names
hCT-MSCsallogeneic human cord tissue mesenchymal stromal cells

Beyond the preview

Go deeper on human cord tissue mesenchymal stromal cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on human cord tissue mesenchymal stromal cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call